SYN Annual Total Expenses
$14.27 M
+$4.11 M+40.49%
31 December 2021
Summary:
As of February 4, 2025, SYN annual total expenses is $14.27 million, with the most recent change of +$4.11 million (+40.49%) on December 31, 2021. During the last 3 years, it has fallen by -$3.30 million (-18.76%).SYN Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Quarterly Total Expenses
$4.99 M
+$733.00 K+17.24%
30 June 2022
Summary:
As of February 4, 2025, SYN quarterly total expenses is $4.99 million, with the most recent change of +$733.00 thousand (+17.24%) on June 30, 2022. Over the past year, it has increased by +$1.79 million (+55.93%).SYN Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.5% | +55.9% |
| 3 y3 years | -18.8% | +37.0% |
| 5 y5 years | -45.6% | -23.0% |
SYN Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -65.2% | -58.1% |
Synthetic Biologics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $4.99 M(+17.2%) |
| Mar 2022 | - | $4.25 M(-19.2%) |
| Dec 2021 | $14.27 M(+40.5%) | $5.26 M(+60.8%) |
| Sept 2021 | - | $3.27 M(+2.4%) |
| June 2021 | - | $3.20 M(+26.0%) |
| Mar 2021 | - | $2.54 M(+19.0%) |
| Dec 2020 | $10.16 M(-35.1%) | $2.13 M(+1.0%) |
| Sept 2020 | - | $2.11 M(-26.9%) |
| June 2020 | - | $2.89 M(-4.6%) |
| Mar 2020 | - | $3.03 M(-5.7%) |
| Dec 2019 | $15.66 M(-10.9%) | $3.21 M(-38.8%) |
| Sept 2019 | - | $5.24 M(+44.1%) |
| June 2019 | - | $3.64 M(+1.8%) |
| Mar 2019 | - | $3.57 M(+9.6%) |
| Dec 2018 | $17.57 M(-33.1%) | $3.26 M(-24.6%) |
| Sept 2018 | - | $4.32 M(-13.7%) |
| June 2018 | - | $5.00 M(+0.3%) |
| Mar 2018 | - | $4.99 M(-13.7%) |
| Dec 2017 | $26.25 M(-33.1%) | $5.78 M(-1.0%) |
| Sept 2017 | - | $5.84 M(-9.8%) |
| June 2017 | - | $6.47 M(-20.5%) |
| Mar 2017 | - | $8.15 M(-20.1%) |
| Dec 2016 | $39.25 M(-4.2%) | $10.20 M(+11.4%) |
| Sept 2016 | - | $9.16 M(-1.7%) |
| June 2016 | - | $9.31 M(-12.0%) |
| Mar 2016 | - | $10.58 M(-7.1%) |
| Dec 2015 | $40.98 M(+99.9%) | $11.39 M(-2.2%) |
| Sept 2015 | - | $11.65 M(+19.7%) |
| June 2015 | - | $9.73 M(+18.6%) |
| Mar 2015 | - | $8.21 M(+15.6%) |
| Dec 2014 | $20.50 M(+66.2%) | $7.10 M(+44.6%) |
| Sept 2014 | - | $4.91 M(+5.6%) |
| June 2014 | - | $4.65 M(+21.2%) |
| Mar 2014 | - | $3.84 M(-10.2%) |
| Dec 2013 | $12.34 M(-28.7%) | $4.27 M(+27.0%) |
| Sept 2013 | - | $3.37 M(+36.7%) |
| June 2013 | - | $2.46 M(+9.9%) |
| Mar 2013 | - | $2.24 M(-81.2%) |
| Dec 2012 | $17.30 M(+191.8%) | $11.89 M(+547.4%) |
| Sept 2012 | - | $1.84 M(+6.6%) |
| June 2012 | - | $1.72 M(-7.1%) |
| Mar 2012 | - | $1.85 M(-33.5%) |
| Dec 2011 | $5.93 M(+60.3%) | $2.79 M(+220.1%) |
| Sept 2011 | - | $871.00 K(+8.2%) |
| June 2011 | - | $805.00 K(-45.0%) |
| Mar 2011 | - | $1.46 M(+381.6%) |
| Dec 2010 | $3.70 M(-2.3%) | $304.00 K(-70.3%) |
| Sept 2010 | - | $1.02 M(-16.3%) |
| June 2010 | - | $1.22 M(+5.8%) |
| Mar 2010 | - | $1.15 M(+3.7%) |
| Dec 2009 | $3.78 M | $1.11 M(+64.3%) |
| Sept 2009 | - | $677.30 K(-23.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $879.60 K(-19.3%) |
| Mar 2009 | - | $1.09 M(+18.4%) |
| Dec 2008 | $7.32 M(-27.8%) | $920.10 K(-37.4%) |
| Sept 2008 | - | $1.47 M(-18.4%) |
| June 2008 | - | $1.80 M(-42.4%) |
| Mar 2008 | - | $3.13 M(-2.8%) |
| Dec 2007 | $10.14 M(+147.0%) | $3.22 M(+48.0%) |
| Sept 2007 | - | $2.17 M(+18.9%) |
| June 2007 | - | $1.83 M(-37.4%) |
| Mar 2007 | - | $2.92 M(+38.1%) |
| Dec 2006 | $4.10 M(+211.1%) | $2.12 M(+179.2%) |
| Sept 2006 | - | $757.60 K(+5.8%) |
| June 2006 | - | $716.20 K(+38.9%) |
| Mar 2006 | - | $515.50 K(-24.1%) |
| Dec 2005 | $1.32 M(-84.0%) | - |
| Mar 2003 | - | $679.40 K(-19.6%) |
| Dec 2002 | $8.26 M(-22.7%) | $845.20 K(-28.2%) |
| Sept 2002 | - | $1.18 M(-62.1%) |
| June 2002 | - | $3.10 M(-0.9%) |
| Mar 2002 | - | $3.13 M(+4.0%) |
| Dec 2001 | $10.68 M(+57.0%) | $3.01 M(+9.4%) |
| Sept 2001 | - | $2.75 M(-10.9%) |
| June 2001 | - | $3.09 M(-71.4%) |
| Mar 2001 | - | $10.79 M(+432.7%) |
| Dec 2000 | $6.80 M(+15.9%) | $2.02 M(+36.8%) |
| Sept 2000 | - | $1.48 M(-9.7%) |
| June 2000 | - | $1.64 M(-1.2%) |
| Mar 2000 | - | $1.66 M(-0.8%) |
| Dec 1999 | $5.87 M(+4.9%) | $1.67 M(+4.5%) |
| Sept 1999 | - | $1.60 M(+14.3%) |
| June 1999 | - | $1.40 M(+14.7%) |
| Mar 1999 | - | $1.22 M(+10.9%) |
| Dec 1998 | $5.60 M(-34.1%) | $1.10 M(-8.3%) |
| Sept 1998 | - | $1.20 M(+9.1%) |
| June 1998 | - | $1.10 M(-50.0%) |
| Mar 1998 | - | $2.20 M(+633.3%) |
| Dec 1997 | $8.50 M(+7.6%) | $300.00 K(-84.2%) |
| Sept 1997 | - | $1.90 M(-44.1%) |
| June 1997 | - | $3.40 M(+25.9%) |
| Mar 1997 | - | $2.70 M(+22.7%) |
| Dec 1996 | $7.90 M(+6.8%) | $2.20 M(-4.3%) |
| Sept 1996 | - | $2.30 M(+35.3%) |
| June 1996 | - | $1.70 M(0.0%) |
| Mar 1996 | - | $1.70 M(-10.5%) |
| Dec 1995 | $7.40 M(+15.6%) | $1.90 M(-9.5%) |
| Sept 1995 | - | $2.10 M(+425.0%) |
| Dec 1994 | $6.40 M(+68.4%) | - |
| Mar 1994 | - | $400.00 K(-66.7%) |
| Dec 1993 | $3.80 M | $1.20 M(-20.0%) |
| Sept 1993 | - | $1.50 M(+200.0%) |
| June 1993 | - | $500.00 K(+25.0%) |
| Mar 1993 | - | $400.00 K |
FAQ
- What is Synthetic Biologics annual total expenses?
- What is the all time high annual total expenses for Synthetic Biologics?
- What is Synthetic Biologics annual total expenses year-on-year change?
- What is Synthetic Biologics quarterly total expenses?
- What is the all time high quarterly total expenses for Synthetic Biologics?
- What is Synthetic Biologics quarterly total expenses year-on-year change?
What is Synthetic Biologics annual total expenses?
The current annual total expenses of SYN is $14.27 M
What is the all time high annual total expenses for Synthetic Biologics?
Synthetic Biologics all-time high annual total expenses is $40.98 M
What is Synthetic Biologics annual total expenses year-on-year change?
Over the past year, SYN annual total expenses has changed by +$4.11 M (+40.49%)
What is Synthetic Biologics quarterly total expenses?
The current quarterly total expenses of SYN is $4.99 M
What is the all time high quarterly total expenses for Synthetic Biologics?
Synthetic Biologics all-time high quarterly total expenses is $11.89 M
What is Synthetic Biologics quarterly total expenses year-on-year change?
Over the past year, SYN quarterly total expenses has changed by +$1.79 M (+55.93%)